These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33200896)

  • 1. The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study.
    Gacci M; Greco I; Artibani W; Bassi P; Bertoni F; Bracarda S; Briganti A; Carmignani G; Carmignani L; Conti GN; Corvò R; DE Nunzio C; Fusco F; Graziotti P; Maggi S; Magrini SM; Mirone V; Montironi R; Muto G; Noale M; Pecoraro S; Porreca A; Ricardi U; Russi E; Salonia A; Simonato A; Serni S; Tubaro A; Zagonel V; Crepaldi G;
    Minerva Urol Nephrol; 2022 Feb; 74(1):38-48. PubMed ID: 33200896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study.
    Porreca A; Noale M; Artibani W; Bassi PF; Bertoni F; Bracarda S; Conti GN; Corvò R; Gacci M; Graziotti P; Magrini SM; Mirone V; Montironi R; Muto G; Pecoraro S; Ricardi U; Russi E; Tubaro A; Zagonel V; Crepaldi G; Maggi S;
    Health Qual Life Outcomes; 2018 Jun; 16(1):122. PubMed ID: 29898750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pros-IT CNR: an Italian prostate cancer monitoring project.
    Noale M; Maggi S; Artibani W; Bassi PF; Bertoni F; Bracarda S; Conti GN; Corvò R; Gacci M; Graziotti P; Magrini SM; Maurizi Enrici R; Mirone V; Montironi R; Muto G; Pecoraro S; Porreca A; Ricardi U; Tubaro A; Zagonel V; Zattoni F; Crepaldi G;
    Aging Clin Exp Res; 2017 Apr; 29(2):165-172. PubMed ID: 28236267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study.
    Palumbo C; Bruni A; Antonelli A; Artibani W; Bassi P; Bertoni F; Borghetti P; Bracarda S; Cicchetti A; Corvò R; Gacci M; Ingrosso G; Magrini SM; Maruzzo M; Mirone V; Montironi R; Muto G; Noale M; Porreca A; Russi E; Triggiani L; Tubaro A; Valdagni R; Maggi S; Conti GN;
    Minerva Urol Nephrol; 2022 Feb; 74(1):11-20. PubMed ID: 33439570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study).
    Antonelli A; Palumbo C; Noale M; Porreca A; Maggi S; Simeone C; Bassi P; Bertoni F; Bracarda S; Buglione M; Conti GN; Corvò R; Gacci M; Mirone V; Montironi R; Triggiani L; Tubaro A; Artibani W;
    Urol Int; 2019; 103(1):8-18. PubMed ID: 30731456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study.
    Gacci M; Artibani W; Bassi P; Bertoni F; Bracarda S; Briganti A; Carmignani G; Carmignani L; Conti G; Corvò R; De Nunzio C; Fusco F; Graziotti P; Greco I; Maggi S; Magrini SM; Mirone V; Montironi R; Morgia G; Muto G; Noale M; Pecoraro S; Porreca A; Ricardi U; Russi E; Russo G; Salonia A; Simonato A; Serni S; Tomasini D; Tubaro A; Zagonel V; Crepaldi G;
    World J Urol; 2021 May; 39(5):1445-1452. PubMed ID: 32740803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' desire to preserve sexual activity and final decision for a nerve-sparing approach: results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study.
    Imbimbo C; Creta M; Gacci M; Simonato A; Gontero P; de Cobelli O; Briganti A; Fulcoli V; Martorana G; Nicita G; Mirone V; Carmignani G
    J Sex Med; 2011 May; 8(5):1495-502. PubMed ID: 21324091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR).
    Buglione M; Noale M; Bruni A; Antonelli A; Bertoni F; Corvo' R; Ricardi U; Borghetti P; Maddalo M; Simeone C; Mazzeo E; Porreca A; Serni S; Bassi P; Gacci M; Mirone V; Montironi R; Tubaro A; Berruti A; Conti GN; Maggi S; Magrini SM; Triggiani L;
    PLoS One; 2019; 14(11):e0224151. PubMed ID: 31675380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival.
    Bakavičius A; Drevinskaitė M; Daniūnaitė K; Barisienė M; Jarmalaitė S; Jankevičius F
    Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32033148
    [No Abstract]   [Full Text] [Related]  

  • 10. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
    Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
    J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index.
    Gacci M; Livi L; Paiar F; Detti B; Litwin MS; Bartoletti R; Giubilei G; Cai T; Mariani M; Carini M
    Urology; 2005 Aug; 66(2):338-43. PubMed ID: 16098363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy.
    Gao Y; Jiang CY; Mao SK; Cui D; Hao KY; Zhao W; Jiang Q; Ruan Y; Xia SJ; Han BM
    Asian J Androl; 2016; 18(4):639-43. PubMed ID: 26732103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual Rehabilitation After Nerve-Sparing Radical Prostatectomy: Free-of-Charge Phosphodiesterase Type 5 Inhibitor Administration Improves Compliance to Treatment.
    Siena G; Mari A; Canale A; Mondaini N; Chindemi A; Greco I; Saleh O; Serni S; Nicita G; Minervini A; Carini M
    J Sex Med; 2018 Feb; 15(2):120-123. PubMed ID: 29425663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.
    Scheltema MJ; van den Bos W; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
    BJU Int; 2017 Nov; 120 Suppl 3():51-58. PubMed ID: 28834167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification.
    Takizawa I; Hara N; Nishiyama T; Kaneko M; Hoshii T; Tsuchida E; Takahashi K
    Asian J Androl; 2009 May; 11(3):283-90. PubMed ID: 19349948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.
    Ferro M; Lucarelli G; Bruzzese D; Di Lorenzo G; Perdonà S; Autorino R; Cantiello F; La Rocca R; Busetto GM; Cimmino A; Buonerba C; Battaglia M; Damiano R; De Cobelli O; Mirone V; Terracciano D
    Oncotarget; 2017 Mar; 8(11):18424-18434. PubMed ID: 27793023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
    Faisal FA; Sundi D; Pierorazio PM; Ball MW; Humphreys EB; Han M; Epstein JI; Partin AW; Carter HB; Bivalacqua TJ; Schaeffer EM; Ross AE
    BJU Int; 2014 Dec; 114(6b):E120-E129. PubMed ID: 24731026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative MRI PI-RADS scores are associated with prostate cancer upstaging on surgical pathology.
    Pockros B; Stensland KD; Parries M; Frankenberger E; Canes D; Moinzadeh A
    Prostate; 2022 Feb; 82(3):352-358. PubMed ID: 34878175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.